Synthetic peptide corresponding to the C terminal region of human FHL3.
Sequence
DQVLCQGCSQAGP
Host
Goat
Clonality
Polyclonal
Isotype
IgG
Conjugate
Unconjugated
Purification
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Concentration
500 µg/ml
Molecular Weight
30 kDa
Predicted MW
31.2kDa
Product Form
Liquid
Formulation
Supplied in Tris Buffered Saline, pH 7.3, with 0.5% BSA and 0.02% Sodium Azide.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze/thaw cycles.
Synonyms
FHL 3, FHL-3, FHL3_HUMAN, Four and a half LIM domains 3, Four and a half LIM domains protein 3, Skeletal muscle LIM protein 2, Skeletal muscle LIM-protein 2, SLIM-2, SLIM2
Figure 1: Western Blot - Anti-FHL3 Antibody (A84043)
FHL3 expression in Human Skeletal Muscle lysate analyzed by western blot. Cells were lysed in RIPA buffer and 35µg protein was run per lane. Primary antibody incubation was performed for 1 hour with Anti-FHL3 Antibody (A84043) at 1µg/ml and detected by chemiluminescence.
Publishing research using Anti-FHL3 Antibody (A84043)? Please let us know so that we can list the citation on this page.
Alternative products to Anti-FHL3 Antibody (A84043)
